Yancey SW - Search Results

1

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.

Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA. Busse W, et al. Among authors: yancey sw. J Allergy Clin Immunol. 1999 Jun;103(6):1075-80. doi: 10.1016/s0091-6749(99)70182-x. J Allergy Clin Immunol. 1999. PMID: 10359889 Clinical Trial.

2

Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.

Busse W, Koenig SM, Oppenheimer J, Sahn SA, Yancey SW, Reilly D, Edwards LD, Dorinsky PM. Busse W, et al. Among authors: yancey sw. J Allergy Clin Immunol. 2003 Jan;111(1):57-65. doi: 10.1067/mai.2003.38. J Allergy Clin Immunol. 2003. PMID: 12532097 Clinical Trial.

3

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.

Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K. Condemi JJ, et al. Ann Allergy Asthma Immunol. 1999 Apr;82(4):383-9. doi: 10.1016/s1081-1206(10)63288-7. Ann Allergy Asthma Immunol. 1999. PMID: 10227337 Clinical Trial.

4

Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.

Nelson HS, Nathan RA, Kalberg C, Yancey SW, Rickard KA. Nelson HS, et al. Among authors: yancey sw. MedGenMed. 2001 Jul 5;3(4):3. MedGenMed. 2001. PMID: 11549982 Clinical Trial.

5

Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.

O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P. O'Connor RD, et al. Among authors: yancey sw. Ann Allergy Asthma Immunol. 2004 Dec;93(6):581-8. doi: 10.1016/S1081-1206(10)61267-7. Ann Allergy Asthma Immunol. 2004. PMID: 15609769

6

Salmeterol compared with current therapies in chronic asthma.

Adinoff AD, Schwartz HJ, Rickard KA, Yancey SW, Swearingen BE. Adinoff AD, et al. Among authors: yancey sw. J Fam Pract. 1998 Oct;47(4):278-84. J Fam Pract. 1998. PMID: 9789513 Clinical Trial.

7

Efficacy of salmeterol xinafoate in the treatment of COPD.

Mahler DA, Donohue JF, Barbee RA, Goldman MD, Gross NJ, Wisniewski ME, Yancey SW, Zakes BA, Rickard KA, Anderson WH. Mahler DA, et al. Among authors: yancey sw. Chest. 1999 Apr;115(4):957-65. doi: 10.1378/chest.115.4.957. Chest. 1999. PMID: 10208192 Free article. Clinical Trial.

8

Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.

Nelson HS, Berkowitz RB, Tinkelman DA, Emmett AH, Rickard KA, Yancey SW. Nelson HS, et al. Among authors: yancey sw. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1556-61. doi: 10.1164/ajrccm.159.5.9807128. Am J Respir Crit Care Med. 1999. PMID: 10228126 Clinical Trial.

9

Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.

Wiegand L, Mende CN, Zaidel G, Zwillich CW, Petrocella VJ, Yancey SW, Rickard KA. Wiegand L, et al. Among authors: yancey sw. Chest. 1999 Jun;115(6):1525-32. doi: 10.1378/chest.115.6.1525. Chest. 1999. PMID: 10378544 Clinical Trial.

10

A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.

Nathan RA, Pinnas JL, Schwartz HJ, Grossman J, Yancey SW, Emmett AH, Rickard KA. Nathan RA, et al. Among authors: yancey sw. Ann Allergy Asthma Immunol. 1999 Jun;82(6):521-9. doi: 10.1016/S1081-1206(10)63159-6. Ann Allergy Asthma Immunol. 1999. PMID: 10400478 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page